» Articles » PMID: 39730325

The Association Between Baseline Viral Load and Long-term Risk in Patients with COVID-19 in Hong Kong: a Territory-wide Study

Abstract

COVID-19 can increase the long-term risk of multiorgan dysfunction. Few studies investigated the long-term risk in Asian populations or investigated the association between viral load and long-term risk. We aimed to investigate the post-discharge rates of hospitalization and association with baseline viral load in all patients with COVID-19 in Hong Kong. This was a population-based cohort study included all patients with a positive RT-PCR test for SARS-CoV-2 in Hong Kong between January 1st 2020 and August 30th 2020, routinely admitted to public health care facilities for isolation and treatment. Viral Ct values were available in 3433 (85%) of patients. Outcomes of interest included death, cause-specific hospitalizations, and initiation of medication from the Hospital Authority's territory-wide electronic health records from the Clinical Data Analysis and Reporting System. In total, 4054 people in Hong Kong tested positive for COVID-19 and were admitted to a public health care facility, of whom 167 (4.1%) were admitted to ICU. During a median follow-up time of 251 (interquartile range 240-279) days, 408 (11.9%) were hospitalized for any reason and 16 (0.5%) patients died. After discharge, patients were most often readmitted for respiratory reasons, followed by gastro-intestinal reasons. A higher viral load (lower RT-PCR Ct values) was associated with a higher likelihood of death (Hazard ratio [HR] 5.86, 95% Confidence interval [CI] 2.57-13.33), hospitalization (HR 1.22, 95%CI 1.08-1.39) or hospitalization for cardiovascular disease (HR 12.78, 95%CI 3.67-44.48). Patients with higher viral loads more likely started ACE-inhibitors (HR 1.37, 95%CI 1.12-1.68) and non-opioid analgesics (HR 1.01, 95%CI 1.01-1.23). In a relatively mild COVID-19 population from Hong Kong, the post-acute risk of complications was substantial. Our results highlight that higher viral load predict post-acute complications in patients with relatively mild disease.

Citing Articles

Novel Oronasal Drainage for Long COVID: Proposed Mechanisms-Case Report.

Lorenz C, Frankenberger R Viruses. 2025; 17(2).

PMID: 40006965 PMC: 11861156. DOI: 10.3390/v17020210.

References
1.
Katsoularis I, Fonseca-Rodriguez O, Farrington P, Lindmark K, Fors Connolly A . Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021; 398(10300):599-607. PMC: 8321431. DOI: 10.1016/S0140-6736(21)00896-5. View

2.
Gue Y, Gorog D . Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19. Eur Heart J. 2020; 41(33):3198-3199. PMC: 7454491. DOI: 10.1093/eurheartj/ehaa534. View

3.
Giron Perez D, Fonseca-Aguero A, Toledo-Ibarra G, Gomez-Valdivia J, Diaz-Resendiz K, Benitez-Trinidad A . Post-COVID-19 Syndrome in Outpatients and Its Association with Viral Load. Int J Environ Res Public Health. 2022; 19(22). PMC: 9690223. DOI: 10.3390/ijerph192215145. View

4.
Cowling B, Ali S, Ng T, Tsang T, Li J, Fong M . Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020; 5(5):e279-e288. PMC: 7164922. DOI: 10.1016/S2468-2667(20)30090-6. View

5.
Lupi L, Adamo M, Inciardi R, Metra M . ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19. Eur Heart J. 2020; 41(33):3200. PMC: 7454504. DOI: 10.1093/eurheartj/ehaa583. View